He is also a Former Chairman of the American Society of Law, Medicine, and Ethics, a Former Vice-Chairman of the Massachusetts 4-H Foundation, and a Former Vice-Chairman of the American Bar Association’s (ABA) Health Law Committee.
Dr. Norris has been a consultant to the senior management of global companies, including: Pfizer, Merck, J&J, and Glaxo.
Dr. Norris received a BA in Economics, with minors in Political Science and Chemical Engineering, from the University of Rochester (where he was a two varsity-sport athlete, and became a member of the university’s Trustee’s Council); a JD with emphasis in health law, corporate law, and international law from Cornell University’s Law School, where he was Editor-in-Chief of The International Law Journal; an MBA with emphasis in healthcare and healthcare-IT policy and management, from Cornell University’s S.C. Johnson Graduate School of Management; and a Graduate Certificate from Harvard University’s Kennedy School of Government. He is also a Former Harvard faculty member, where he taught health policy and management, including healthcare-IT reform, healthcare-delivery-system reform, and FDA reform.
According to HDC Board Chairman, Dr. Joe McKenzie, “John has served with distinction for the past three years, and we intend to rely on his global vision of the future of healthcare-delivery-system reform, of healthcare-IT reform, and of FDA reform to drive the transformation of HDC into its next phase of growth.”HDC Director, Dr. Herb Fritsche stated, “I have known John for a long time and have worked closely with him over the past three years. I can attest to his impeccable personal integrity, intellectual honesty, outstanding vision, and keen knowledge, insights, and judgment regarding the future of advanced healthcare technology, healthcare-delivery-system reform, healthcare-IT reform, and FDA reform. His strong business reputation, and his exceptional advisory and executive capabilities, are all well known to me.” HDC Director, Mr. Sumio Takeichi commented, “I have worked closely with John for nearly 20 years, both on boards and in business ventures, and I, too, can attest to his honesty, integrity, courage, insight, and intelligence when under pressure. He has the best values, capabilities, and experiences of anyone I know, for teasing potential out of HDC’s technologies and turning the Company’s fortunes in a strongly positive direction. His availability and his willingness to take on that challenge are both God sends.”
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts